Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)-Reference-Cited by-同舟云学术

Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)

Published:2014-02-15 Issue:4 Volume:73 Page:819-825
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Koinis Filippos,Polyzos Aristidis,Christopoulou Athina,Zafeiriou Zafeiris,Emmanouilidis Christos,Papadimitraki Elisavet,Kalykaki Antonia,Kalbakis Kostas,Samonis George,Georgoulias Vassilis

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-014-2411-2.pdf

Reference38 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90. doi: 10.3322/caac.20107

2. SEER Stat Fact Sheets: Ovary Cancer (2013) http://seer.cancer.gov/statfacts/html/ovary.html

3. Elit L, Hirte H (2013) Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options. Onco Targets Ther 6:107–118. doi: 10.2147/OTT.S30238

4. Markman M, Rothman R, Hakes T, Reichman B, Hoskins W, Rubin S, Jones W, Almadrones L, Lewis JL Jr (1991) Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. J Clin Oncol 9(3):389–393

5. Fung-Kee-Fung M, Oliver T, Elit L, Oza A, Hirte HW, Bryson P (2007) Optimal chemotherapy treatment for women with recurrent ovarian cancer. Curr Oncol 14(5):195–208

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicities of different first-line chemotherapy regimens in the treatment of advanced ovarian cancer;Medicine;2017-01

2. Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging;Journal of Controlled Release;2016-05